ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

COMPLETED

Weill Cornell Medical College - New York Presbyterian Hospital, New York

RECRUITING

Maryland Oncology Hematology, P.A., Columbia

RECRUITING

Virginia Cancer Specialists, Fairfax

RECRUITING

Messino Cancer Center, Asheville

RECRUITING

D&H Cancer Research Center, LLC, Margate

RECRUITING

BRCR Global, Plantation

RECRUITING

Urology Associates, P.C., Nashville

RECRUITING

University of Michigan Rogel Cancer Center, Ann Arbor

WITHDRAWN

Hematology Oncology Clinic, Baton Rouge

RECRUITING

The First Affiliated Hospital of Xi'an Jiaotang University, Xi'an

RECRUITING

Texas Oncology - Central South, Austin

RECRUITING

Colorado Urology, Lakewood

RECRUITING

California Research Institute, Los Angeles

RECRUITING

Innovative Clinical Research Institute, Whittier

RECRUITING

University of California, San Francisco, San Francisco

RECRUITING

Northwest Cancer Specialists, P.C., Portland

RECRUITING

Seattle Cancer Care Alliance, Seattle

WITHDRAWN

Liaoning Cancer Hospital, Shenyang

RECRUITING

Fudan University Shanghai Cancer Center, Shanghai

RECRUITING

Shanghai Tenth People's Hospital, Shanghai

RECRUITING

Nanjing Drum Tower Hospital, Nanjing

RECRUITING

Anhui Provincial Hospital, Hefei

RECRUITING

Zhejiang Provincial People's Hospital, Hangzhou

RECRUITING

The First Affiliated Hospital of Xiamen University, Xiamen

RECRUITING

Chongqing Cancer Hospital, Chongqing

RECRUITING

Hunan Cancer Hospital, Changsha

RECRUITING

Tongji Hospital of Tongji Medical College, Huazhong University of Science & Technology, Wuhan

RECRUITING

Hubei Cancer Hospital, Wuhan

RECRUITING

Henan Cancer Hospital, Zhengzhou

RECRUITING

Sichuan Provincial People's Hospital, Chengdu

RECRUITING

First Hospital of Shanxi Medical University, Taiyuan